Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Publication year range
1.
J Exp Med ; 199(3): 357-68, 2004 Feb 02.
Article in English | MEDLINE | ID: mdl-14757742

ABSTRACT

Wiskott-Aldrich syndrome protein-interacting protein (WIP) stabilizes actin filaments and is important for immunoreceptor-mediated signal transduction leading to actin cytoskeleton rearrangement in T and B cells. Here we report a role for WIP in signaling pathways downstream of the high affinity receptor for immunoglobulin (Ig)E (FcepsilonRI) in mast cells. WIP-deficient bone marrow-derived mast cells (BMMCs) were impaired in their capacity to degranulate and secrete interleukin 6 after FcepsilonRI ligation. Calcium mobilization, phosphorylation of Syk, phospholipase C-g2, and c-Jun NH2-terminal kinase were markedly decreased in WIP-deficient BMMCs. WIP was found to associate with Syk after FcepsilonRI ligation and to inhibit Syk degradation as evidenced by markedly diminished Syk levels in WIP-deficient BMMCs. WIP-deficient BMMCs exhibited no apparent defect in their subcortical actin network and were normal in their ability to form protrusions when exposed to an IgE-coated surface. However, the kinetics of actin changes and the cell shape changes that follow FcepsilonRI signaling were altered in WIP-deficient BMMCs. These results suggest that WIP regulates FcepsilonRI-mediated mast cell activation by regulating Syk levels and actin cytoskeleton rearrangement.


Subject(s)
Carrier Proteins/physiology , Mast Cells/immunology , Receptors, IgE/immunology , Wiskott-Aldrich Syndrome/immunology , Actins/physiology , Animals , B-Lymphocytes/immunology , Bone Marrow Cells/immunology , Carrier Proteins/genetics , Cytoskeletal Proteins , Gene Deletion , Histamine Release , Humans , Intracellular Signaling Peptides and Proteins , Mice , Mice, Knockout , T-Lymphocytes/immunology
2.
Toxicol Appl Pharmacol ; 235(1): 105-13, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-19095001

ABSTRACT

In addition to cancer endpoints, arsenic exposures can also lead to non-cancerous chronic lung disease. Exposures during sensitive developmental time points can contribute to the adult disease. Using a mouse model, in utero and early postnatal exposures to arsenic (100 ppb or less in drinking water) were found to alter airway reactivity to methacholine challenge in 28 day old pups. Removal of mice from arsenic exposure 28 days after birth did not reverse the alterations in sensitivity to methacholine. In addition, adult mice exposed to similar levels of arsenic in drinking water did not show alterations. Therefore, alterations in airway reactivity were irreversible and specific to exposures during lung development. These functional changes correlated with protein and gene expression changes as well as morphological structural changes around the airways. Arsenic increased the whole lung levels of smooth muscle actin in a dose dependent manner. The level of smooth muscle mass around airways was increased with arsenic exposure, especially around airways smaller than 100 microm in diameter. This increase in smooth muscle was associated with alterations in extracellular matrix (collagen, elastin) expression. This model system demonstrates that in utero and postnatal exposure to environmentally relevant levels of arsenic can irreversibly alter pulmonary structure and function in the adults.


Subject(s)
Arsenic/toxicity , Lung Diseases/chemically induced , Lung Diseases/pathology , Lung/growth & development , Lung/physiology , Aging , Animals , Animals, Newborn , Collagen/metabolism , Dose-Response Relationship, Drug , Elastin/metabolism , Female , Gene Expression Regulation, Developmental/drug effects , Lung/drug effects , Male , Mice , Mice, Inbred C57BL , Muscle, Smooth/drug effects , Muscle, Smooth/pathology , Muscle, Smooth/physiology , Pregnancy , Prenatal Exposure Delayed Effects
3.
Int Immunol ; 15(12): 1431-40, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645152

ABSTRACT

Wiskott-Aldrich syndrome protein (WASP) is the product of the gene deficient in boys with X-linked Wiskott-Aldrich syndrome. We assessed the role of WASP in signaling through the high-affinity IgE receptor (FcepsilonRI) using WASP-deficient mice. IgE-dependent degranulation and cytokine secretion were markedly diminished in bone marrow-derived mast cells from WASP-deficient mice. Upstream signaling events that include FcepsilonRI-triggered total protein tyrosine phosphorylation, and protein tyrosine phosphorylation of FcepsilonRIbeta and Syk were not affected by WASP deficiency. However, tyrosine phosphorylation of phospholipase Cgamma and Ca(2+) mobilization were diminished. IgE-dependent activation of c-Jun N-terminal kinase, cell spreading and redistribution of cellular F-actin in mast cells were reduced in the absence of WASP. We conclude that WASP regulates FcepsilonRI-mediated granule exocytosis, cytokine production and cytoskeletal changes in mast cells.


Subject(s)
Mast Cells/physiology , Proteins/physiology , Receptors, IgE/physiology , Signal Transduction/physiology , Actins/analysis , Actins/metabolism , Animals , Blotting, Western , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Calcium/metabolism , Cell Degranulation/physiology , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Surface Extensions/drug effects , Dinitrophenols/immunology , Dinitrophenols/pharmacology , Female , Flow Cytometry , Histamine/blood , Immunization, Passive , Immunoglobulin E/analysis , Immunoglobulin E/immunology , Immunoglobulin E/pharmacology , Interleukin-3/pharmacology , Interleukin-6/genetics , Interleukin-6/metabolism , JNK Mitogen-Activated Protein Kinases , Male , Mast Cells/chemistry , Mice , Mice, Knockout , Microscopy, Fluorescence , Mitogen-Activated Protein Kinases/metabolism , Nerve Tissue Proteins/analysis , Phospholipase C gamma , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Proteins/analysis , Proteins/genetics , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Receptor Aggregation/immunology , Receptors, IgE/metabolism , Serum Albumin/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Type C Phospholipases/metabolism , Wiskott-Aldrich Syndrome Protein , Wiskott-Aldrich Syndrome Protein, Neuronal , beta-N-Acetylhexosaminidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL